Sanguine BioSciences Named Bronze Sponsor of Alzheimer's Association Walk to End Alzheimer's™
VALENCIA, Calif., Oct 30, 2012 /PRNewswire/ -- SANGUINE BIOSCIENCES, INC, a biotechnology company providing transparency to patients in biomedical research, was named a Bronze Sponsor by the Alzheimer's Association California Southland Chapter. The Company is not only contributing financially, but its management team will be participating in the walk.
From the Alzheimer's Association's website: "The Walk to End Alzheimer'sTM is the nation's largest event to raise awareness and funds for Alzheimer's care, support and research. Held annually in more than 600 communities nationwide, this inspiring event calls on participants of all ages and abilities to reclaim the future for millions. Together, we can end Alzheimer's disease, the nation's sixth-leading cause of death."
Sanguine BioSciences will sponsor the Alzheimer's Association Walk to End Alzheimer's™ event on Sunday, November 4 at Century Park, 2000 Ave. of the Stars, Los Angeles, CA. Registration and check-in opens at 7:00 a.m. PST, opening ceremonies commence at 8:30 a.m., and the event begins at 9:00 a.m. You can participate in the event by starting or joining a team, walking as an individual, or sending in your donations.
"Sponsoring the Walk to Remember TM is an example of the cornerstone of our business' mission – to directly engage patients in biomedical research and to provide transparency in the process. Non-profit curated events are of particular interest to us, because it provides the Company with the unique opportunity to communicate our mission directly to patients and their families, face-to-face, as opposed to exclusively employing the social web. We're excited to sponsor this event and many more in the near future." – Carlyn Crisostomo, Vice President, Clinical Strategy & Operations.
If you would like to join the Sanguine Team or volunteer for the event, visit: donate.sanguinebio.com.
About Alzheimer's Association
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's research, care and support. Its mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Their vision is a world without Alzheimer's. For more information visit www.alz.org or call 24/7: (800) 272-3900.
Sanguine BioSciences is a biotechnology company that engages patients in biomedical research by delivering transparency throughout the research process. The company collects and de-identifies patient-derived data in the form of biospecimen, and physician and self-reported information. The data generated is then made commercially available to researchers involved in in silico and in vitro research. (http://sanguinebio.com)
SOURCE Sanguine BioSciences, Inc.; INVENT Ventures Inc.